🇺🇸 FDA
Patent

US 12421220

Bicyclic-substituted glutarimide cereblon binders

granted A61KA61K31/4709A61K31/496

Quick answer

US patent 12421220 (Bicyclic-substituted glutarimide cereblon binders) held by C4 THERAPEUTICS, INC. expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4 THERAPEUTICS, INC.
Grant date
Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/4709, A61K31/496, A61K31/5377, A61K31/5383